Salt water infusion could boost brain injury recovery

NCT ID NCT07319208

First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times

Summary

This study tests whether giving a continuous infusion of concentrated salt water (hypertonic saline) early after severe traumatic brain injury can improve survival and daily living independence at 6 months. About 760 patients with a low Glasgow Coma Scale score and high risk of brain swelling will receive the infusion for 48 hours. The goal is to reduce pressure inside the skull and protect the brain.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
hypertonic saline solution (concentrated salt water)
What this could lead to
If it works, this could offer a simple, widely available treatment to help more people survive traumatic brain injury and regain independence.
What could go wrong
This is a large phase 3 trial, but the treatment is only for a specific high-risk group and may not improve outcomes for all. Side effects like high sodium or chloride levels need careful monitoring.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TBI (TRAUMATIC BRAIN INJURY) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Brain Injuries, Traumatic traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AP-HM

    NOT_YET_RECRUITING

    Marseille, France

  • CH de Annecy Genevois

    NOT_YET_RECRUITING

    Épagny, France

  • CHRU de Tours

    NOT_YET_RECRUITING

    Tours, France

  • CHU Caen Normandie

    RECRUITING

    Caen, France

  • CHU Henri Mondor APHP

    RECRUITING

    Créteil, France

  • CHU Lariboisière, AP-HP

    NOT_YET_RECRUITING

    Paris, France

  • CHU d'Angers

    NOT_YET_RECRUITING

    Angers, France

  • CHU de Brest

    RECRUITING

    Brest, France

  • CHU de Clermont- Ferrand

    RECRUITING

    Clermont-Ferrand, France

  • CHU de Grenoble

    NOT_YET_RECRUITING

    Grenoble, France

  • CHU de Lille

    RECRUITING

    Lille, France

  • CHU de Nancy

    NOT_YET_RECRUITING

    Nancy, France

  • CHU de Nantes

    RECRUITING

    Nantes, France

  • CHU de Nice

    RECRUITING

    Nice, France

  • CHU de Poitiers

    NOT_YET_RECRUITING

    Poitiers, France

  • CHU de Rennes

    RECRUITING

    Rennes, France

  • CHU de Rouen

    NOT_YET_RECRUITING

    Rouen, France

  • CHU de St- Etienne

    NOT_YET_RECRUITING

    Saint-Etienne, France

  • CHU de Strasbourg

    NOT_YET_RECRUITING

    Strasbourg, France

  • CHU de Toulouse

    RECRUITING

    Toulouse, France

  • GHU Paris Cité

    NOT_YET_RECRUITING

    Paris, France

  • HCL

    NOT_YET_RECRUITING

    Lyon, France

  • Hôpital BEAUJON APHP

    RECRUITING

    Clichy, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.